GCKR Polymorphisms Increase the Risks of Low Bone Mineral Density in Young and Non‐Obese Patients With MASLD and Hyperuricemia
ABSTRACT Metabolic‐associated steatotic liver disease (MASLD) encompasses common comorbidities including low bone mineral density (BMD) and hyperuricemia (HU), yet relevant genetic analyses are limited. This study aimed to investigate the genetic effects of risk single nucleotide polymorphisms (SNPs...
Saved in:
| Main Authors: | Tzu‐Hao Li, Yu‐Shin Huang, Chia‐Chen Ma, Shin‐Yu Tsai, Hung‐Cheng Tsai, Hsiao‐Yun Yeh, Hsiao‐Chin Shen, Shiao‐Ya Hong, Chien‐Wei Su, Hwai‐I Yang, Ying‐Ying Yang, Ming‐Chih Hou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-06-01
|
| Series: | Kaohsiung Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/kjm2.70017 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Hyperuricemia—Especially “Metabolic Hyperuricemia”—Is Independently Associated with a Higher Risk of Steatotic Liver Disease
by: Janis Timsans, et al.
Published: (2025-05-01) -
Analysis of ABCG2 gene rs2231142 single nucleotide polymorphism and risk factors in hyperuricemia
by: Meiting Liang, et al.
Published: (2025-03-01) -
Research progress in fructose induced hyperuricemia and renal injury
by: ZHANG Yu-ting, et al.
Published: (2019-01-01) -
The gut microbiome: a vital link to hyperuricemia, gout and acute flares?
by: Wei Wang, et al.
Published: (2025-08-01) -
The role of Triglyceride Glucose-Waist Circumference (TyG_WC) in predicting metabolic dysfunction-associated steatotic liver disease among individuals with hyperuricemia
by: Qian-Qian Wang, et al.
Published: (2025-04-01)